LIPID OXIDATION-PRODUCTS HAVE OPPOSITE EFFECTS ON CALCIFYING VASCULARCELL AND BONE CELL-DIFFERENTIATION - A POSSIBLE EXPLANATION FOR THE PARADOX OF ARTERIAL CALCIFICATION IN OSTEOPOROTIC PATIENTS
F. Parhami et al., LIPID OXIDATION-PRODUCTS HAVE OPPOSITE EFFECTS ON CALCIFYING VASCULARCELL AND BONE CELL-DIFFERENTIATION - A POSSIBLE EXPLANATION FOR THE PARADOX OF ARTERIAL CALCIFICATION IN OSTEOPOROTIC PATIENTS, Arteriosclerosis, thrombosis, and vascular biology, 17(4), 1997, pp. 680-687
Atherosclerotic calcification and osteoporosis often coexist in patien
ts, yielding formation of bone mineral in vascular walls and its simul
taneous loss from bone. To assess the potential role of lipoproteins i
n both processes, we examined the effects of minimally oxidized low-de
nsity lipoprotein (MM-LDL) and several other lipid oxidation products
on calcifying vascular cells (CVCs) and bone-derived preosteoblasts MC
3T3-E1. In CVCs, MM-LDL but not native LDL inhibited proliferation, ca
used a dose-dependent increase in alkaline phosphatase activity, which
is a marker of osteoblastic differentiation, and induced the formatio
n of extensive areas of calcification. Similar to MM-LDL, oxidized toy
l-2-arachidonoyl-sn-glycero-3-phosphorylcholine (ox-PAPC) and the isop
rostane 8-iso prostaglandin E-2 but not PAPC or isoprostane 8-iso pros
taglandin F-2 alpha induced alkaline phosphatase activity and differen
tiation of CVCs. In contrast, MM-LDL and the above oxidized lipids inh
ibited differentiation of the MC3T3-E1 bone cells, as evidenced by the
ir stimulatory effect on proliferation and their inhibitory effect on
the induction of alkaline phosphatase and calcium uptake. These result
s suggest that specific oxidized lipids may be the common factors unde
rlying the pathogenesis of both atherosclerotic calcification and oste
oporosis.